HYMPAVZI 150 mg/mL
marstacimab-hncq · INJECTION, SOLUTION · Pfizer Laboratories Div Pfizer Inc
HYMPAVZI is a injection, solution containing marstacimab-hncq at 150 mg/mL, taken subcutaneous. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- HYMPAVZI
- Generic Name
- marstacimab-hncq
- NDC Code (Product)
0069-2151- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 150 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761369
- Marketing Start
- 11/05/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is HYMPAVZI used for?
HYMPAVZI contains marstacimab-hncq. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is HYMPAVZI a controlled substance?
HYMPAVZI is not classified as a controlled substance by the DEA.
What is the generic name for HYMPAVZI?
The generic name for HYMPAVZI is marstacimab-hncq. There are no other listed brand versions of marstacimab-hncq.
What is the NDC code for HYMPAVZI 150 mg/mL?
The NDC (National Drug Code) for HYMPAVZI 150 mg/mL is 0069-2151, listed by Pfizer Laboratories Div Pfizer Inc.
Other HYMPAVZI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)